1. NECTIN4 Expression in Extramammary Paget’s Disease: Implication of a New Therapeutic Target
   Maho Murata et al, 2020, International Journal of Molecular Sciences CrossRef
2. High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
   Xuequan Wang et al, 2022, Frontiers in Oncology CrossRef
3. Current and Emerging Treatments for Urothelial Carcinoma: A Focus on Enfortumab Vedotin
   Muhammad Ashir Shafique et al, 2023, Cancer Management and Research CrossRef
4. The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment
   Da Som Choi et al, 2021, The Korean Journal of Urological Oncology CrossRef
5. Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma
   Sarah E. Fenton et al, 2023, Frontiers in Oncology CrossRef
6. Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of Cancer
   Gemma E. Mudd et al, 2022, Journal of Medicinal Chemistry CrossRef
7. Nectin-4 is widely expressed in head and neck squamous cell carcinoma
   Christine Sanders et al, 2022, Oncotarget CrossRef
8. Enfortumab Vedotin-ejfv: A First-in-Class Anti–Nectin-4 Antibody-Drug Conjugate for the Management of Urothelial Carcinoma
   Zachery Halford et al, 2021, Annals of Pharmacotherapy CrossRef
9. Prognostic value of nectin-4 in human cancers: A meta-analysis
   Rongqiang Liu et al, 2023, Frontiers in Oncology CrossRef
10. NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach
    Christine Bekos et al, 2019, Cancers CrossRef
11. The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
    Andres Garcia-Sampedro et al, 2021, Journal of Clinical Medicine CrossRef